PY1850855A - Nueva sal de n-(2,6-dietilfenil)-8-({4-[4-(dimetilamino)piperidin-1-il]-2-metoxifenil}amino)-1-metil-4,5-dihidro-1h-pirazolo[4,3-h]quinazolina-3-carboxamida, su preparación y las formulaciones que las contienen - Google Patents
Nueva sal de n-(2,6-dietilfenil)-8-({4-[4-(dimetilamino)piperidin-1-il]-2-metoxifenil}amino)-1-metil-4,5-dihidro-1h-pirazolo[4,3-h]quinazolina-3-carboxamida, su preparación y las formulaciones que las contienenInfo
- Publication number
- PY1850855A PY1850855A PY201801850855A PY1850855A PY1850855A PY 1850855 A PY1850855 A PY 1850855A PY 201801850855 A PY201801850855 A PY 201801850855A PY 1850855 A PY1850855 A PY 1850855A PY 1850855 A PY1850855 A PY 1850855A
- Authority
- PY
- Paraguay
- Prior art keywords
- diethylphenyl
- pyrazolo
- quinazoline
- piperidin
- methoxyphenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17305826 | 2017-06-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PY1850855A true PY1850855A (es) | 2019-04-01 |
Family
ID=59313166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PY201801850855A PY1850855A (es) | 2017-06-29 | 2018-06-28 | Nueva sal de n-(2,6-dietilfenil)-8-({4-[4-(dimetilamino)piperidin-1-il]-2-metoxifenil}amino)-1-metil-4,5-dihidro-1h-pirazolo[4,3-h]quinazolina-3-carboxamida, su preparación y las formulaciones que las contienen |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US11160806B2 (https=) |
| EP (1) | EP3645535B1 (https=) |
| JP (1) | JP7141416B2 (https=) |
| KR (1) | KR102609333B1 (https=) |
| CN (1) | CN110896636B (https=) |
| AR (1) | AR112040A1 (https=) |
| AU (1) | AU2018293729B9 (https=) |
| CA (1) | CA3068357C (https=) |
| CL (1) | CL2019003848A1 (https=) |
| EA (1) | EA039764B1 (https=) |
| ES (1) | ES2900048T3 (https=) |
| IL (1) | IL271628B2 (https=) |
| MA (1) | MA49498A (https=) |
| PL (1) | PL3645535T3 (https=) |
| PY (1) | PY1850855A (https=) |
| SG (1) | SG11201912651WA (https=) |
| TW (1) | TWI750393B (https=) |
| UY (1) | UY37778A (https=) |
| WO (1) | WO2019002454A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025002962A1 (en) | 2023-06-30 | 2025-01-02 | Nerviano Medical Sciences S.R.L. | Use of a mps1 inhibitor for the treatment of hepatocellular carcinoma |
| WO2025021587A1 (en) | 2023-07-21 | 2025-01-30 | Nerviano Medical Sciences S.R.L. | Combination of a mps1 inhibitor and immune checkpoint inhibitors, uses and pharmaceutical compositions thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA020703B9 (ru) * | 2008-06-26 | 2015-12-30 | Ле Лаборатуар Сервье | Пиразолохиназолины |
-
2018
- 2018-06-21 UY UY0001037778A patent/UY37778A/es not_active Application Discontinuation
- 2018-06-28 PL PL18732820T patent/PL3645535T3/pl unknown
- 2018-06-28 EP EP18732820.8A patent/EP3645535B1/en active Active
- 2018-06-28 MA MA049498A patent/MA49498A/fr unknown
- 2018-06-28 PY PY201801850855A patent/PY1850855A/es unknown
- 2018-06-28 AR ARP180101781A patent/AR112040A1/es unknown
- 2018-06-28 CN CN201880043442.0A patent/CN110896636B/zh active Active
- 2018-06-28 US US16/624,488 patent/US11160806B2/en active Active
- 2018-06-28 CA CA3068357A patent/CA3068357C/en active Active
- 2018-06-28 EA EA202090115A patent/EA039764B1/ru unknown
- 2018-06-28 WO PCT/EP2018/067394 patent/WO2019002454A1/en not_active Ceased
- 2018-06-28 TW TW107122235A patent/TWI750393B/zh active
- 2018-06-28 KR KR1020207002339A patent/KR102609333B1/ko active Active
- 2018-06-28 JP JP2019572116A patent/JP7141416B2/ja active Active
- 2018-06-28 AU AU2018293729A patent/AU2018293729B9/en active Active
- 2018-06-28 ES ES18732820T patent/ES2900048T3/es active Active
- 2018-06-28 SG SG11201912651WA patent/SG11201912651WA/en unknown
-
2019
- 2019-12-22 IL IL271628A patent/IL271628B2/en unknown
- 2019-12-26 CL CL2019003848A patent/CL2019003848A1/es unknown
-
2021
- 2021-09-30 US US17/490,318 patent/US20220016122A1/en not_active Abandoned
-
2024
- 2024-07-01 US US18/760,494 patent/US20240350501A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN110896636B (zh) | 2022-07-19 |
| US11160806B2 (en) | 2021-11-02 |
| EP3645535B1 (en) | 2021-09-08 |
| MA49498A (fr) | 2021-05-26 |
| WO2019002454A1 (en) | 2019-01-03 |
| AU2018293729B9 (en) | 2022-07-14 |
| CL2019003848A1 (es) | 2020-07-10 |
| IL271628A (en) | 2020-02-27 |
| AU2018293729A1 (en) | 2020-01-23 |
| BR112019027924A2 (pt) | 2020-08-18 |
| TWI750393B (zh) | 2021-12-21 |
| AR112040A1 (es) | 2019-09-11 |
| CA3068357A1 (en) | 2019-01-03 |
| ES2900048T3 (es) | 2022-03-15 |
| EP3645535A1 (en) | 2020-05-06 |
| CA3068357C (en) | 2022-04-19 |
| IL271628B1 (en) | 2023-03-01 |
| TW201904971A (zh) | 2019-02-01 |
| PL3645535T3 (pl) | 2022-03-21 |
| AU2018293729B2 (en) | 2022-03-10 |
| UY37778A (es) | 2019-01-31 |
| CN110896636A (zh) | 2020-03-20 |
| EA202090115A1 (ru) | 2020-05-25 |
| US20220016122A1 (en) | 2022-01-20 |
| KR102609333B1 (ko) | 2023-12-01 |
| US20200246339A1 (en) | 2020-08-06 |
| JP7141416B2 (ja) | 2022-09-22 |
| JP2020525477A (ja) | 2020-08-27 |
| IL271628B2 (en) | 2023-07-01 |
| SG11201912651WA (en) | 2020-01-30 |
| KR20200020905A (ko) | 2020-02-26 |
| US20240350501A1 (en) | 2024-10-24 |
| EA039764B1 (ru) | 2022-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125007T1 (el) | Ενωσεις και χημικες συνθεσεις ως αναστολεις ενδοσωμικων υποδοχεων τυπου toll | |
| MX372934B (es) | Compuestos de imidazopiridina y sus usos. | |
| CY1121170T1 (el) | Νεες ενωσεις ως ρυθμιστες πρωτεϊνικων κινασων | |
| JOP20180116A1 (ar) | H1- بيرازولو [4، 3-b] بيريدينات كمثبطات PDE1 | |
| ECSP088350A (es) | Pirazolopirimidinas como inhibidores de protein quinasas | |
| BR112018071216A2 (pt) | inibidores de bromodomínios | |
| BR112017003054A2 (pt) | compostos de aminopirimidinila como inibidores de jak | |
| BR112015022643A2 (pt) | inibidores diidro-pirrolpiridinona | |
| BR112017002811A2 (pt) | compostos de pirrolopirimidina usados como agonista de tlr7 | |
| MX2020007271A (es) | Sales y cristales novedosos. | |
| BR112017002942A2 (pt) | compostos e derivados de espiro[3h-indol-3,2´-pirrolidin]2(1h)-ona como inibidores de mdm2-p53 | |
| EA201290131A1 (ru) | Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний | |
| CO7170166A2 (es) | Inhibidores de pi3k delta selectivos | |
| MX2019012847A (es) | Compuestos de c5-anilinoquinazolina y su uso en el tratamiento del cancer. | |
| EA202090258A2 (ru) | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ | |
| AR071120A1 (es) | Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas. | |
| EA201591541A1 (ru) | Ингибиторы бета-секретазы 1 (bace 1) | |
| ECSP16074478A (es) | Compuestos novedosos | |
| MX2015017512A (es) | Compuestos 2,3-dihidrobenzofuran-5-ilicos como inhibidores de cinasas dyrk. | |
| EA201591904A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ N-(2,3-ДИГИДРО-1H-ПИРРОЛО[2,3-b]ПИРИДИН-5-ИЛ)-4-ХИНАЗОЛИНАМИНА И N-(2,3-ДИГИДРО-1H-ИНДОЛ-5-ИЛ)-4-ХИНАЗОЛИНАМИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PERK | |
| EA201792057A1 (ru) | Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы | |
| EA201891319A1 (ru) | Соединения алкилдигидрохинолинсульфонамида | |
| JOP20170115B1 (ar) | مشتقات بيريدينيل، تركيبات صيدلية منها واستخداماتها كمثبطات aoc3 | |
| BR112019007591A2 (pt) | inibidores de bromodomínios | |
| BR112018004347A2 (pt) | derivados de éter cíclico de pirazolo[1,5-a]pirimidina-3-carboxiamida |